WASHINGTON - Members of a House subcommittee on Thursday were pointing their fingers in all sorts of directions, looking for someone to accept blame for the debacle surrounding ImClone Systems Inc.'s investigational cancer drug, Erbitux.(BioWorld Today) Read More